Health digest: hepatitis B therapy, migraine drug, WHO race
· 8 source(s)
Short summary
Medical Xpress reports an experimental gene-silencing therapy offers hope for a hepatitis B cure, and that a Lund University study found lamotrigine reduced monthly aura days by at least half in 85% of aura-dominant migraine patients. MD Anderson researchers developed an AI model using routine imaging to flag lung cancer patients at risk of immunotherapy-related lung inflammation, while Duncan NRI and Baylor researchers reported in Nature Cancer that stroke promotes glioma growth. Oxford-led research in Nature Cities links coal-fired power growth in India to rising urban air pollution deaths.
Mind map
Health news roundup
Drag to pan · pinch or the + / − buttons to zoom · swipe up or down to scroll the page.
Read the map as an outline
-
Hepatitis B and migraine
-
Gene-silencing hepatitis B therapy
- Medical Xpress reports experimental therapy offers hope
- Chronic HBV affects about 240 million worldwide
-
Lamotrigine for migraine aura
- Lund University study in Sweden
- 85% had aura days cut by half
-
Gene-silencing hepatitis B therapy
-
Cancer and stroke research
-
AI predicts immunotherapy lung risk
- MD Anderson model uses routine imaging
- Aims at personalized monitoring before treatment
-
Stroke promotes glioma growth
- Reported in Nature Cancer
- Duncan NRI and Baylor researchers involved
-
AI predicts immunotherapy lung risk
-
Environment and air pollution
-
Coal power and India air deaths
- Oxford-led study published in Nature Cities
- Electricity access rose as coal reliance grew
-
Urban pollution mortality rise
- Sharp rise in urban air pollution deaths
-
Coal power and India air deaths
-
Tobacco and FDA comments
-
Menthol ban comment campaign
- STAT reports 175,000 comments on 2022 proposal
- Most were form letters, JAMA study finds
-
Industry talking points echoed
- STAT says most echoed tobacco industry points
-
Menthol ban comment campaign
-
WHO leadership race
-
Five candidates for director-general
- STAT reports at least five candidates
- Questions over U.S. role loom
-
Challenges ahead for next leader
- STAT says job comes with extraordinary challenges
-
Five candidates for director-general
-
Deprescribing medications
-
Stopping medications discussion
- Medical Xpress lists four things to know
- Asks when a doctor last suggested stopping
-
Role of doctors and pharmacists
- Item frames deprescribing as a question to raise
-
Stopping medications discussion
Map your own version
This post is a mind map of what today's sources reported. Start with a blank canvas and build the same thing for whatever you are working on — it opens straight away, no account needed until you want to keep it.
Sources
- Four things you need to know about deprescribing — Medical Xpress - latest medical and health news stories
- Experimental gene-silencing therapy offers hope for hepatitis B cure — Medical Xpress - latest medical and health news stories
- Anti-epileptic drug may reduce migraine aura — Medical Xpress - latest medical and health news stories
- AI model uses routine imaging to identify patients at risk for serious treatment-induced lung inflammation — Medical Xpress - latest medical and health news stories
- Stroke may change brain cells in ways that help gliomas grow — Medical Xpress - latest medical and health news stories
- Coal-powered economic growth linked to rising urban air pollution and deaths in India — Medical Xpress - latest medical and health news stories
- How Big Tobacco flooded the FDA with public comments to kill a menthol cigarette ban — STAT
- At least five candidates vie to become the next WHO leader, as questions over U.S. role loom — STAT
Written by an AI model from the sources listed above, then published without edits. It summarises what those sources reported and adds nothing of its own — for the full story, follow the links. Model: deepseek-chat.
More health
- Health digest: diabetes cancer risk, dementia research, fibromyalgia pathways — Sep 24, 2026
- Health news: dementia resource, FDA studies, alcohol warnings, e-bikes, diabetes, conception, AI screening, ultra-processed food — Sep 23, 2026
- Health digest: FDA approves first Alexander disease drug — Sep 22, 2026
- Health studies cover postpartum pain, Alzheimer's genes and ingestible batteries — Sep 21, 2026
- Health: Cortisol, Dementia Risk, Drug Safety, Ebola, Measles, West Nile, Malaria, Outbreaks — Sep 20, 2026